HomeNewsBusinessWith companies taking remote working seriously, co-working spaces are taking a hit

With companies taking remote working seriously, co-working spaces are taking a hit

According to a reports, office space absorption could see a degrowth of 6 percent and that will impact co-working spaces too

June 05, 2020 / 20:31 IST
Story continues below Advertisement

Remote working by employees in small to mid-size tech firms is probably here to stay as companies look to downsize real estate and pause their expansion plans in co-working spaces.

This will impact the co-working industry in the country, which has been growing at a fast pace in the last couple of years.

Story continues below Advertisement

Manav Garg, founder, EKA Software, a software-as-a-service (SaaS), said work from home (WFH) will become a permanent feature for the company. “We will reduce dependence on real estate and capacity in co-working spaces,” he said.

Another entrepreneur Pallav Nadhani, who recently sold his firm FushionCharts and is already on to his next venture, said the company is pausing its expansion plans in the co-working spaces. The company reduced its capacity after its contract ended in a co-working space.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show